Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
4 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Activation of Tumor-Cell STING Primes NK-Cell Therapy.
Cancer Immunol Res. 2022 Aug 3;10(8):947-961. doi: 10.1158/2326-6066.CIR-22-0017.
Cancer Immunol Res. 2022.
PMID: 35678717
Free PMC article.
EDIL3 as an Angiogenic Target of Immune Exclusion Following Checkpoint Blockade.
Tabasum S, Thapa D, Giobbie-Hurder A, Weirather JL, Campisi M, Schol PJ, Li X, Li J, Yoon CH, Manos MP, Barbie DA, Hodi FS.
Tabasum S, et al. Among authors: schol pj.
Cancer Immunol Res. 2023 Nov 1;11(11):1493-1507. doi: 10.1158/2326-6066.CIR-23-0171.
Cancer Immunol Res. 2023.
PMID: 37728484
Free PMC article.
Item in Clipboard
Single-cell transcriptomics in bone marrow delineates CD56dimGranzymeK+ subset as intermediate stage in NK cell differentiation.
Melsen JE, van Ostaijen-Ten Dam MM, Schoorl DJA, Schol PJ, van den Homberg DAL, Lankester AC, Lugthart G, Schilham MW.
Melsen JE, et al. Among authors: schol pj.
Front Immunol. 2022 Nov 24;13:1044398. doi: 10.3389/fimmu.2022.1044398. eCollection 2022.
Front Immunol. 2022.
PMID: 36505452
Free PMC article.
Item in Clipboard
Extensive androgen receptor enhancer heterogeneity in primary prostate cancers underlies transcriptional diversity and metastatic potential.
Kneppers J, Severson TM, Siefert JC, Schol P, Joosten SEP, Yu IPL, Huang CF, Morova T, Altıntaş UB, Giambartolomei C, Seo JH, Baca SC, Carneiro I, Emberly E, Pasaniuc B, Jerónimo C, Henrique R, Freedman ML, Wessels LFA, Lack NA, Bergman AM, Zwart W.
Kneppers J, et al.
Nat Commun. 2022 Nov 30;13(1):7367. doi: 10.1038/s41467-022-35135-2.
Nat Commun. 2022.
PMID: 36450752
Free PMC article.
Item in Clipboard
Cite
Cite